1. Home
  2. VERU vs LEE Comparison

VERU vs LEE Comparison

Compare VERU & LEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERU
  • LEE
  • Stock Information
  • Founded
  • VERU 1971
  • LEE 1890
  • Country
  • VERU United States
  • LEE United States
  • Employees
  • VERU N/A
  • LEE N/A
  • Industry
  • VERU Biotechnology: Pharmaceutical Preparations
  • LEE Newspapers/Magazines
  • Sector
  • VERU Health Care
  • LEE Consumer Discretionary
  • Exchange
  • VERU Nasdaq
  • LEE Nasdaq
  • Market Cap
  • VERU 108.8M
  • LEE 90.6M
  • IPO Year
  • VERU 1990
  • LEE N/A
  • Fundamental
  • Price
  • VERU $0.57
  • LEE $10.44
  • Analyst Decision
  • VERU Strong Buy
  • LEE
  • Analyst Count
  • VERU 4
  • LEE 0
  • Target Price
  • VERU $4.00
  • LEE N/A
  • AVG Volume (30 Days)
  • VERU 6.2M
  • LEE 19.1K
  • Earning Date
  • VERU 02-13-2025
  • LEE 02-06-2025
  • Dividend Yield
  • VERU N/A
  • LEE N/A
  • EPS Growth
  • VERU N/A
  • LEE N/A
  • EPS
  • VERU N/A
  • LEE N/A
  • Revenue
  • VERU $16,886,419.00
  • LEE $600,264,000.00
  • Revenue This Year
  • VERU N/A
  • LEE N/A
  • Revenue Next Year
  • VERU N/A
  • LEE N/A
  • P/E Ratio
  • VERU N/A
  • LEE N/A
  • Revenue Growth
  • VERU 22.46
  • LEE N/A
  • 52 Week Low
  • VERU $0.49
  • LEE $7.57
  • 52 Week High
  • VERU $1.92
  • LEE $19.63
  • Technical
  • Relative Strength Index (RSI)
  • VERU 44.48
  • LEE 25.74
  • Support Level
  • VERU $0.49
  • LEE $11.11
  • Resistance Level
  • VERU $0.56
  • LEE $11.69
  • Average True Range (ATR)
  • VERU 0.05
  • LEE 0.62
  • MACD
  • VERU 0.00
  • LEE -0.10
  • Stochastic Oscillator
  • VERU 63.62
  • LEE 6.16

About VERU Veru Inc.

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.

About LEE Lee Enterprises Incorporated

Lee Enterprises Inc is a local news publication company in the United States. It is a digital-first subscription business providing local markets with valuable, high-quality, trusted, intensely local news, information, advertising, and marketing services. The product portfolio of the company includes digital subscription platforms, daily, weekly, and monthly newspapers, and niche products, all delivering original local news and information as well as national and international news. The products offer digital and print editions, and content and advertising are available in real-time through the websites and mobile apps.

Share on Social Networks: